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ABSTRACT 26 
Scope 27 
During food processing the Maillard reaction (МR) may occur resulting in the formation of 28 
glycated proteins. Glycated proteins are of particular importance in food allergy since 29 
glycation may influence interactions with immune system. This study compared native and 30 
extensively glycated milk allergen β-lactoglobulin (BLG), in their interactions with cells 31 
crucially involved in allergy. 32 
Methods and results 33 
BLG was glycated in MR and characterized. Native and glycated BLG were tested in 34 
experiments of epithelial transport, uptake and degradation by DCs, T-cell cytokine responses 35 
and basophil cell degranulation using ELISA and flow cytometry. Glycation of BLG induced 36 
partial unfolding and reduced its intestinal epithelial transfer over a Caco-2 monolayer. 37 
Uptake of glycated BLG by bone marrow-derived dendritic cells (BMDC) was increased, 38 
although both BLG forms entered BMDC via the same mechanism, receptor-mediated 39 
endocytosis. Once inside the BMDC, glycated BLG was degraded faster, which might have 40 
led to observed lower cytokine production in BMDC/CD4+ T-cells coculture. Finally, 41 
glycated BLG was less efficient in induction of degranulation of BLG-specific IgE sensitized 42 
basophil cells. 43 
Conclusions 44 
This study suggests that glycation of BLG by MR significantly alters its fate in processes 45 
involved in immunogenicity and allergenicity, pointing out the importance of food processing 46 
in food allergy. 47 
  48 
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1. INTRODUCTION 49 
Nowadays, the majority of food is subjected to thermal treatment prior to consumption, 50 
which induces structural and chemical modifications of food proteins. One of the most 51 
widespread modifications is glycation by the Maillard reaction (MR), a very complex 52 
reaction cascade that occurs between amino and carbonyl groups [1]. Products of MR are very 53 
diverse and give rise to a variety of glycation structures covalently attached to food proteins 54 
that are collectively termed as Advanced Glycation Endproducts (AGEs). Glycated proteins 55 
possess many functional properties that are relevant for food industry such as improved 56 
gelling, emulsifying and foaming activity, increased temperature and pH stability and 57 
increased antioxidant activity [2-6], but also characteristics that are attractive for consumers 58 
such as appealing color, smell, taste and texture [7].  59 
Apart from improving techno-functional properties, MR also alters biological and 60 
immunological properties of food proteins. It is well documented that glycation of food 61 
allergens affects their IgE binding ability by direct masking of linear as well as 62 
conformational epitopes, leading to reduced allergenicity [8, 9]. In contrast, other studies have 63 
pointed out that glycation led to formation of neoantigens, hereby increasing their recognition 64 
by IgE antibodies [10-12]. Recently, evidences are emerging that effects of MR on food 65 
allergens go beyond IgE recognition. Dendritic cells (DCs), as the most important antigen-66 
presenting cells in the immune system, possess several receptors that recognize glycation 67 
structures, including receptor for Advanced Glycation Endproducts (RAGE), Scavenger 68 
Receptors (SRs), galectin-3 and CD-36 [13, 14]. Acting through these receptors, glycation 69 
structures may influence recognition, uptake and processing of food allergens by DCs. 70 
Subsequently, this may have consequences on the maturation of DCs and subsequent 71 
activation of naïve T-cells. For instance, a glycated form of the major egg allergen, 72 
ovalbumin (OVA) binds to SR class A which mediates increased allergen uptake by DCs, and 73 
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leads  to a stronger T helper type 2 cytokine response [15, 16]. Similarly, AGE-BSA induced 74 
maturation of DCs and augmented their capacity to stimulate T-cell proliferation and 75 
cytokine secretion [17]. It has even been speculated that AGEs of food allergens interact with 76 
DCs, promote immune responses and contribute to development of food allergy by 77 
mimicking endogenous danger signals [18]. 78 
Very little is known about allergen processing and degradation inside DCs, despite that this is 79 
of great importance. It has been described that the dynamics of uptake and degradation inside 80 
endolysosomal compartments of DCs affects class II MHC loading pathways, antigen 81 
presentation and finally T-cell polarization [19-21].  82 
β-Lactoglobulin (BLG) is the most abundant whey protein and one of the major allergens in 83 
milk [22]. Whey proteins are frequently used as food additives because of their valuable 84 
nutritional and techno-functional properties. Thus, they are very likely to be glycated in MR 85 
upon food processing. There are scare literature data about the effects of the MR on the 86 
immunogenic properties of the major whey allergen. Hence, the aim of this study was to 87 
glycate BLG with glucose to a high extent and to conduct a comparative analysis, relative to 88 
its native form, regarding their behavior in processes that are involved in immunogenicity and 89 
allergenicity. Intestinal epithelial transcytosis, uptake and degradation by BMDCs, ability to 90 
induce cytokine production by BLG-specific CD4+ T-cells and basophil degranulation 91 
capacity of native and glycated BLG were investigated. 92 
2. METHODS 93 
2.1. Chemicals and standards 94 
Unless otherwise stated, all chemicals were obtained from Sigma-Aldrich (St. Louis, MO, 95 
USA). For all experiments Milli-Q water (Millipore, France) was used. 96 
2.2. Mice 97 
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Five-week-old female C3H/HeOuJ mice were purchased from Charles River (France) and 98 
were maintained in specific pathogen-free conditions within the animal care facility at the 99 
Utrecht University. Experiments were approved by the Animal Experiments Committee of 100 
the Utrecht University. 101 
2.3. Protein sample preparation 102 
BLG was isolated from raw cow’s milk as described previously [23] (details are given in 103 
supplementary material). Purity of the obtained BLG preparation was estimated to be >95% 104 
by SDS-PAGE. Protein concentration was determined by bicinhoninic acid (BCA) assay 105 
(Pierce, Amsterdam, The Netherlands). Endotoxin was reduced from samples by affinity 106 
chromatography on ε-poly-L-lysine cellulose beads (Thermo Scientific, Rockford, IL). The 107 
residual amount of endotoxin was determined using LAL Chromogenic Endotoxin 108 
Quantitation Kit (Thermo Scientific, Rockford, IL). The endotoxin concentration in BLG 109 
sample was 0.4 EU/mg of protein. 110 
2.4. Glycation procedure and characterization of glycated BLG 111 
Glycated BLG was made by performing the MR in which 10 mg/ml BLG was incubated with 112 
180 mg/ml glucose in 50 mM phosphate buffer, pH 8.0 at 60˚C for 10 days in capped vials. 113 
Thermally treated BLG under the same conditions but without glucose was also prepared. To 114 
determine the degree of glycation, free amino groups were estimated by the ortho-115 
phthalaldehyde (OPA) method as described previously [24]. To further characterize glycated 116 
BLG, SDS-PAGE was performed on 14% gel (5 μg of protein per lane, under reducing and 117 
non-reducing conditions. Protein bands were visualized by Coomassie Brilliant Blue staining. 118 
Structural changes were monitored by recording far-UV CD spectra on a JASCO J-815 119 
spectropolarimeter (JASCO, Tokyo, Japan) of 0.85 mg/ml native and glycated BLG in 50 120 
mM sodium phosphate buffer pH 8.0. Each spectrum was acquired four times, and the results 121 
were averaged. Spectra were analyzed by the CONTIN program to determine the proportion 122 
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of secondary structures based on reference protein set of 29 soluble proteins – SP29 as 123 
previously was done [23]. 124 
2.5. Caco-2 cell culture 125 
The culturing of Caco-2 cells is described in Supplementary material. 126 
2.6. Transport across Caco-2 cell monolayer 127 
For transport studies, Caco-2 cells were seeded at 1.6 × 104 cells/insert on polycarbonate 128 
membranes with a pore size of 0.1 μm in 24-well plates (Transwell, Corning Costar, 129 
Cambridge, MA). Cells at passages of 17-25 were used in experiments. Prior to the transport 130 
studies transepithelial electrical resistance (TEER) was measured using Millicell-ERS 131 
VoltOhmmeter (Millipore, Amsterdam, The Netherlands). Only cell monolayers with 132 
TEER>500 Ω were used. Native and glycated BLG were diluted in DMEM culture medium 133 
to a final concentration of 1.5 mg/ml, and 100 µl of these preparations were loaded onto 134 
apical surface of Caco-2 monolayer, while 600 µl of DMEM culture medium was added to 135 
the receiver compartment. Aliquots of 30 µl were withdrawn from the receiver compartment 136 
after 15, 30, 60, 120, 240, and 300 min and receiver compartment was replenished every time 137 
with medium. Transported native and glycated BLG were detected by commercially available 138 
ELISA kit (Bethyl Laboratories, Inc., Montgomery) according to manufacturer’s instructions. 139 
2.7. Generation of Bone Marrow-derived Dendritic Cells (BMDCs) 140 
Bone marrow cells isolated from femurs/tibias of naïve C3H/HeOuJ mice were cultured in 141 
conditioned- complete DCs medium (RPMI 1640 medium glutaMAX (Gibco, Invitrogen, 142 
Carlsbad, USA)) supplemented with 10% heat-inactivated FCS, 1 mM sodium pyruvate, 100 143 
units/ml penicillin, 100 μg/ml streptomycin, 1% nonessential amino acids, 0.1 mM 2-144 
mercaptoethanol), with 10 ng/ml GM-CSF (R&D, Oxon, UK) at 37 °C in a humidified 145 
atmosphere of 5% CO2. Medium was refreshed on day 3. Only 6-day old BMDCs were used 146 
for the following experiments. 147 
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2.8. Allergen uptake by BMDCs 148 
Native and glycated BLG were labeled with FITC according to the manufacturer’s 149 
instructions (Sigma-Aldrich, St. Louis, MO, USA). FITC-native BLG and FITC-glycated 150 
BLG conjugates were separated from unreacted FITC label using PD-10 desalting column 151 
(GE Healthcare, Uppsala, Sweden). The labeling efficacy was the same for native and 152 
glycated BLG as determined by absorbance at 280 and 495nm. The concentration of labeled 153 
samples was determined by BCA assay, and the samples were stored protected from light at -154 
20 °C until use. 155 
FITC-native and FITC-glycated BLG (10 μg/ml) were incubated with 1 × 106 BMDCs/ml of 156 
cell culture medium for 0, 5, 10, 20, 30, 45, 60, 90 and 120 min at 37 °C. Uptake was 157 
recorded using BD Accuri C6 Cytometer (BD Biosciences, San Jose, CA, USA). Mean 158 
fluorescence intensity (MFI) and percentage of FITC-positive BMDCs were calculated using 159 
BD Accuri C6 software. 160 
2.9. Mechanistic studies of allergen uptake by BMDCs 161 
To identify uptake mechanism for native and glycated BLG, BMDCs were pretreated with 10 162 
μg/ml latrunculin B, 1 µM jasplakinolide 2 mM amiloride, 2 μM phenylarsine oxide, 163 
inhibitors of phagocytosis, macropinocytosis and receptor-mediated endocytosis, 164 
respectively. To inhibit uptake mediated by specific receptors, BMDCs were incubated with 165 
the following inhibitors: 100 μg/ml dextran sulfate, or 200 μg/ml polyinosine specific for 166 
SRs, and 0.3 µM FPS-ZM1 specific for RAGE. After 30 min of incubation at 37 °C with the 167 
above inhibitors, BMDCs were loaded with 10 μg/ml FITC-native BLG and FITC-glycated 168 
BLG. Uptake was recorded after 30 min of incubation at 37 °C by flow cytometry as 169 
described above. 170 
2.10 Confocal microscopy 171 
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1x105 BMDCs in the presence or absence of different inhibitors under above described 172 
conditions were withdrawn, washed and spun onto glass slides by cytospin. Cells were 173 
imaged on a Leica TCS SPE-2 confocal laser scanning-microscope on a DMI4000. 174 
2.11. Endolysosomal degradation assay 175 
Native and glycated BLG were covalently coupled to polystyrene beads (Polysciences, Inc., 176 
Warrington, PA, USA) (protocol included in Supplementary material). 177 
Endolysosomal degradation was estimated according to Hoffmann E. et al. [25] with minor 178 
modifications. Total of 12.5 x 106 of BMDCs from naïve mice were incubated with 50 x 106 179 
of native and glycated BLG-coated beads at 37 °C for 15 min to allow phagocytosis. 180 
Phagocytosis was stopped by adding ice-cold PBS. Non-internalized beads were washed out 181 
3 times with FCS floatation cushion at +4 °C. BMDCs were resuspended in 2.5 ml of 182 
conditioned-complete DCs medium and incubated at 37 °C to start phagosome maturation. 183 
Aliquots of 480 μl were withdrawn after 0, 30, 120, 240 and 720 min and immediately mixed 184 
with 1 ml of ice-cold PBS to stop phagosome maturation, and centrifuged for 5 min at 400g 185 
at 4 °C. Pelleted BMDCs were lysed with lysis buffer (50 mM Tris, 150 mM NaCl, 0.5% 186 
Triton x, 1 mM DTT, 10 μg/ml Dnase I, pH 7.4, with addition of complete protease inhibitor 187 
cocktail (Roche, Lewes, UK)), overnight, at 4 °C. Non-degraded BLG on the beads surface 188 
was detected using rabbit polyclonal anti-BLG antibody 1:1000 (Fitzgerald, 70R-LR011) and 189 
anti-rabbit Alexa 488 antibody (Invitrogen A11034). Alexa intensity was measured by flow 190 
cytometry. 191 
2.12. Assessment of T-cell Activation and Cytokine Production 192 
BLG-specific CD4+ T-cells were obtained from spleens of C3H/HeOuJ mice immunized with 193 
BLG and aluminum hydroxide (Imject Alum, Pierce, Netherlands). On days 0 and 7, three 194 
mice were intraperitoneally injected with 100 μg of native BLG and 1 mg of ALUM. On day 195 
14, BMDCs from naïve mice were primed with 50 μg/ml of different forms of BLG for 2 h. 196 
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BMDCs were scraped, washed, and transferred to a 48-well plate where they were cocultured 197 
(1:10 cell number ratio) with freshly isolated CD4+ T-cells for the next 72 h. Subsequently, 198 
levels of IFN-γ, IL-5, IL-10 and IL-13 were measured in coculture supernatants by 199 
commercially available ELISA (e-Bioscience, Austria). 200 
2.13. Anti-BLG IgE crosslinking-induced NFAT-responsive luciferase in basophilic RS-201 
ATL8 cells 202 
The humanized rat basophilic leukemia cell line RS-ATL8 was kindly provided by R. 203 
Nakamura from the National Institute for Health Sciences, Tokyo, Japan. This cell line which 204 
was established by introducing the NFAT-responsive luciferase gene into human FcεRI 205 
expressing RBL-SX38 cells was used to measure IgE crosslinking-induced luciferase 206 
expression (EXiLE). EXiLE assay was performed as described previously [26] with slight 207 
modifications. RS-ATL8 cells (5 × 104 cells/50 μl/well) in 96-wells flat bottom culture plate 208 
were sensitized overnight with a pool of six anti-BLG chimeric IgE monoclonal antibodies (1 209 
μg/ml each individual humanized IgE) [27]. Cells were washed once with sterile PBS and then 210 
stimulated for 1h at 37 °C in a 5% CO2 incubator with 50 µl/well of native and glycated BLG 211 
diluted in MEM containing 10% FCS in four different concentrations (1, 10, 100 and 1000 212 
ng/ml) or with 1 µg/ml goat anti-human IgE antibodies (DakoCytomation, Glostrup, 213 
Denmark) as control. After stimulation, 50 µl of luciferase substrate solution containing cell 214 
lysis reagent (ONE-Glo, Promega Corp., Tokyo, Japan) was added to the cells, and 215 
chemiluminescence was measured. Luciferase expression levels are represented as the fold 216 
increase of relative light units compared with the background expression. 217 
2.14. Statistical analysis 218 
Data are presented as mean ± stand deviation (SD) or standard error of mean (SEM) and 219 
analyzed using GraphPad Prism software (La Jolla, CA). Data were tested by Student’s t-test. 220 
Differences were considered significant when p-values were <0.05. 221 
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3. RESULTS 222 
3.1. BLG was glycated to a high extent accompanied by modifications in secondary 223 
structure. 224 
BLG was glycated with glucose in the MR, and the degree of glycation was assessed by 225 
determining the free amino group content by OPA method (Fig. 1A). A significant loss of 226 
available amino groups was observed; about 75% of amino groups were glycated. 227 
Analysis of native and glycated BLG by SDS-PAGE showed a band at 18 kDa, 228 
corresponding to BLG (Fig. 1B). This band smeared toward higher molecular masses after 229 
conjugation with glucose molecules. Under non-reducing conditions, BLG dimers were 230 
present in both, native and glycated BLG, while under reducing conditions, native BLG was 231 
visible only in monomeric form, but glycated BLG was still visible in dimeric form, 232 
indicating the formation of covalent bonds other than disulfide bridges. Glycation reaction 233 
also induced covalent aggregates formation, noticeable as higher molecular masses at the 234 
interface of stacking and running gels. 235 
Changes were observed in far-UV CD spectra of glycated BLG compared to native BLG 236 
spectra (Fig. 1C). The characteristic minimum of native BLG at 215 nm was shifted toward a 237 
lower wavelength, indicating a decrease in the ordered secondary structure. Software analysis 238 
of CD spectra showed a decrease in α-helix accompanied with an increase in random coils 239 
(Fig. 1D), suggesting a direct conversion of regular into irregular structures upon glycation. 240 
In addition, thermal treatment of BLG without glucose led to different changes in structure 241 
and a higher extent of aggregate formation in comparison to glycated BLG, as evidenced by 242 
SDS-PAGE under reducing and non-reducing conditions (Fig. S1A and B). Also, far-UV CD 243 
spectra analysis showed differences in the structural change of heated and glycated BLG in 244 
comparison to native BLG. Heated BLG showed a significantly higher loss of β-sheets (Fig. 245 
S2A and B). The protective effect of sugar on the heat-induced denaturation and aggregation 246 
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of BLG has been shown extensively before [5, 24, 28, 29]. Therefore structural changes induced 247 
by Maillard reaction are not simple the sum of thermally induced structural changes and 248 
covalent attachment of sugar moieties. Thus, native BLG, rather than heated BLG, was used 249 
as control in order to compare their interactions with immune cells crucially involved in 250 
cow`s milk allergy. 251 
3.2. Glycation of BLG reduced transport across Caco-2 cell monolayer. 252 
Transport of BLG samples across Caco-2 cell monolayer, a model of intestinal barrier 253 
function, was examined. Native and glycated BLG were applied on apical side of Caco-2 254 
cells and transport was followed in time by determining BLG concentration on basal side. 255 
Glycation reaction dramatically reduced detection of BLG at basolateral side of Caco-2 256 
monolayer (Fig. 2). Transport of both native and glycated BLG was continuous, verifying 257 
intactness of Caco-2 monolayer and preserved tight junctions during experiment. 258 
3.3. Glycation of BLG increased uptake by BMDCs.  259 
Further, we investigated whether glycation through MR influences interactions of BLG with 260 
BMDCs. FITC-labeled native and glycated BLG were incubated with BMDCs, and BLG 261 
uptake was followed in time by flow cytometry. Uptake of both BLG forms, measured as 262 
percent of FITC-positive cells (Fig. 3A) was time dependent and reached plateau after 30 263 
minutes, while the MFI (Fig. 3B) continuously increased up to 120 minutes. Glycated BLG 264 
was taken up more efficiently reaching 85% of FITC-positive BMDCs compared to 55% 265 
when incubated with native BLG. Significantly increased uptake of glycated BLG was also 266 
observed when MFI was measured. 267 
Confocal micrographs were in agreement with the findings obtained by flow cytometry, 268 
BMDCs displayed a higher fluorescent signal upon incubation with glycated BLG (Fig. 3C). 269 
3.4. Glycated BLG entered BMDCs via receptor-mediated endocytosis, involving 270 
scavenger receptors. 271 
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To understand the process of uptake by BMDCs of native and glycated BLG, we inhibited 272 
several possible uptake routes. First, BMDCs were incubated at 4 °C to stop all active cellular 273 
processes. This led to almost complete reduction of native and glycated BLG uptake (Fig. 274 
4A), indicating that the uptake was active and by an energy dependent process. Second, 275 
pretreatment with latrunculin B and jasplakinolide, which are known to interfere with actin 276 
polymerization and therefore inhibit phagocytosis, reduced uptake of both BLG forms (Fig. 277 
4A and C). This suggested that actin and phagocytosis were involved in the uptake process. 278 
Third, amiloride, an inhibitor of macropinocytosis, also decreased uptake of both BLG forms 279 
(Fig. 4A and C). Final, pretreatment of BMDCs with phenylarsine oxide, an inhibitor of the 280 
internalization of cell surface receptors, resulted in a strong inhibition of the endocytosis of 281 
native BLG, while almost completely abrogated uptake of glycated BLG (Fig. 4A and C). 282 
Taken together, inhibition studies showed that native and glycated BLG entered BMDCs in 283 
actin-dependent process and phagocytosis, by constitutive macropinocytosis and by receptor-284 
mediated endocytosis.  285 
Additionally, in an attempt to identify receptor(s) involved in the uptake of native and 286 
glycated BLG, inhibitors for specific endocytic receptors were used. Both dextran sulfate and 287 
polyinosine, inhibitors of SRs, remarkably reduced the uptake of both BLG forms (Fig. 4B 288 
and D). Treatment of BMDCs with FPS-ZM1, a RAGE inhibitor, did not significantly affect 289 
uptake of any BLG form (Fig. 4B and D). This suggests that both BLG forms bind to and 290 
being internalized via SRs at least to some extent. Redirection of glycated BLG uptake 291 
towards receptor-mediated endocytosis could be caused by stronger recognition by SRs due 292 
to changes in physicochemical properties that followed the MR. 293 
3.5. Glycated BLG showed higher susceptibility to endolysosomal degradation inside 294 
BMDCs. 295 
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Efficient intracellular antigen degradation and processing is of crucial importance for antigen 296 
presentation. We therefore compared endolysosomal proteolysis of native and glycated BLG 297 
within BMDCs. BMDCs were allowed to phagocytose native and glycated BLG coupled to 298 
polystyrene beads, and endolysosomal degradation of allergens was determined by BLG-299 
specific antibody binding. Significant lower antibody binding to glycated BLG after first 30 300 
min of degradation indicated that glycation influenced degradation kinetics, making glycated 301 
protein more susceptible to proteolysis especially at  first time (Fig. 5). 302 
3.6. Glycated BLG induced lower CD4+ T-cell cytokine responses. 303 
To assess the specific T-cell responses to glycated BLG, BLG-specific CD4+ T-cells were 304 
isolated from mice immunized to native BLG and cocultured with BMDCs primed with 305 
native or glycated BLG. After coculture, glycated BLG-primed BMDCs induced lower 306 
production of INF-γ, IL-5 and IL-13 by T cells, when compared with native BLG-primed 307 
BMDCs (Fig. 6). Both native and glycated BLG-primed BMDCs equally induced IL-10 308 
production. 309 
3.7. Glycation of BLG reduced basophil activation 310 
Finally, to gain insight into the effects of glycated BLG on allergic effector responses, a 311 
basophil cell elicitation test was performed. RS-ATL8 cells were sensitized with oligoclonal 312 
anti-BLG specific humanized IgE antibodies and subsequently native or glycated BLG was 313 
added. Glycated BLG induced significantly lower basophil activation compared to native 314 
BLG at all tested concentrations (Fig. 7). 315 
4. DISCUSSION 316 
Thermally processed food is highly consumed in the Western diet nowadays. Food 317 
processing can induce multiple biochemical reactions in food including MR which cause 318 
glycation of food proteins and formation of AGEs. Glycation of food allergens may have an 319 
impact on allergenicity but there is no conclusive data on how these modifications alter 320 
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allergenic manifestations. The immunomodulatory effects of AGEs structures have been 321 
described in literature (reviewed in [18, 30-33]). For instance, the effects of MR on 322 
immunogenicity and allergenicity of food allergen OVA have also been studied and have 323 
shown an elevated risk of food allergy [15, 16, 34]. We aimed to describe how glycation reaction 324 
of the major milk allergen, BLG, influences handling and processing by epithelial and 325 
dendritic cells. 326 
In order to exert a possible immunological effect, glycated proteins must be able to pass 327 
the intestinal epithelial barrier and to get in contact with immune system. Transport of 328 
allergens can occur transcellularly or paracellularly through intestinal epithelial cells. The 329 
main route of in vivo intestinal absorption of native BLG is through epithelial cells [35, 36]. We 330 
compared the transfer of native and glycated BLG using the well-known in vitro Caco-2 cell 331 
monolayer system for testing intestinal barrier function. We showed that both native and 332 
glycated BLG are able to cross the Caco-2 monolayer, although the MR drastically reduced 333 
transcytosis of BLG. This could have been caused by the physicochemical changes in BLG 334 
induced by glycation, such as partial unfolding, and formation of high molecular weight 335 
species which can make transcytosis more difficult. Reduced intestinal permeability would 336 
result in lower allergen uptake and may hence reduce activation of sensitized lamina propria 337 
mast cells and subsequent anaphylactic responses [37]. Roth et al. reported that pasteurization 338 
of the BLG and α-lactalbumin protected against an anaphylactic reaction, since uptake 339 
through epithelial cells was impaired due to aggregation [36]. Furthermore, in our basophil 340 
activation experiments, glycation of BLG reduced its capacity to crosslink FcεRI receptors on 341 
RBL cells. In extensively glycated BLG all residues containing free amino group (16 lysines, 342 
2 arginines and N-terminal amino group of Leu 1) seem to be glycated [38, 39], while all of the 343 
BLG-specific chimeric human IgE monoclonal antibodies used in this study recognize 344 
peptides containing at least 1-2 residues with possible glycation sites[27]. Therefore, it is 345 
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highly likely that extensive BLG glycation reduced mAb IgE binding by changing epitope 346 
structure, and led to reduced basophil activation. Additionally, previous studies showed a 347 
masking effect of glycation with different monosaccharides on IgE binding properties of 348 
BLG [8]. This effect of high degree of glycation on recognition of food allergens by IgE 349 
antibodies has been well documented in literature [8, 9, 40]. Lower allergic effector responses 350 
(as measured by ability to induce crosslinking of FcεRI receptors), together with much lower 351 
intestinal transport (as measured in transcytosis Caco-2 experiment) suggest that glycation of 352 
BLG reduces the risk of allergic or even anaphylactic reactions. 353 
To further characterize the down-stream processing of glycated BLG we examined its uptake 354 
and degradation by murine BMDCs. We found that the uptake of glycated BLG by immature 355 
BMDCs was significantly increased, compared to uptake of native BLG, at every measured 356 
time-point. The same was observed for uptake of glycated OVA by either murine BMDCs or 357 
human myeloid DCs [15, 16, 34]. In addition, we used pharmacological inhibitors which interfere 358 
with different internalization pathways. Phenylarsine oxide inhibited the uptake of both 359 
native and glycated BLG, indicating that receptor-mediated endocytosis is involved in 360 
internalization process. The more pronounced inhibition of glycated BLG uptake, compared 361 
to inhibition of native BLG uptake, in the presence of phenylarsine oxide indicates a shift of 362 
glycated BLG uptake to receptor-mediated endocytosis. To execute their role, BMDCs are 363 
equipped with a full array of specialized receptors, including pattern-recognition receptors 364 
(PRRs) such as Toll-like receptors (TLRs), C-type lectins (CTLs) and SRs. Literature 365 
suggests that some allergens interact with PRR and hereby stimulate innate and adaptive 366 
responses [41]. Considering their role in recognizing glycated products we selectively blocked 367 
SRs and RAGE and found that SRs were responsible for the uptake of both native and 368 
glycated BLG. Our findings are in accordance with previously published data that AGEs 369 
structures of glycated proteins bind to SR class A [34, 42]. Interestingly, SRs ligands are 370 
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polyanionic molecules [43] and BLG is an acidic protein with pI value 5.1, which can explain 371 
its binding to SRs. Blocking of lysyl residues by sugar moieties in MR lowers pI value and 372 
makes glycated BLG even more acidic, possibly leading to higher binding affinity for SRs 373 
and consequently higher uptake by BMDCs. Another factor influencing faster uptake could 374 
be changed folding and increased aggregation that accompanied the glycation reaction. 375 
Similarly, pyrraline, an AGEs structure, when attached to OVA has been suggested to 376 
promote SR class A-mediated allergen uptake by DCs [34]. 377 
In spite of the much higher uptake by BMDCs through SR-mediated endocytosis, glycated 378 
BLG showed lower CD4+ T-cell stimulation. Glycated BLG-primed BMDCs in coculture 379 
with BLG-specific CD4+ T-cells showed significantly lower production of Th1- (INF-γ) and 380 
Th2-type cytokines (IL-5 and IL-13) when compared with native BLG-primed BMDCs. This 381 
indicated that there was less peptide loading of MHC class II when BMDCs were primed 382 
with glycated BLG. Previously published results, showing that glycated OVA was taken up 383 
by DCs via SR class A type I and type II-mediated endocytosis, followed with enhanced 384 
CD4+ T-cell responses [15], are in contrast with our findings and indicate that overall effect on 385 
T-cell responses is carbohydrate- and allergen-dependent. These findings also stress the 386 
importance of events that follow antigen internalization i.e. antigen processing and activation 387 
of downstream signaling pathways. In support of our observations, Smole et al. reported that 388 
immature monocyte-derived DCs were able to internalize potent allergen Bet v 1 and its 389 
structural homolog, but weak allergen, Api g 1 with the similar kinetics, and furthermore, 390 
there was no difference in the uptake by DCs from healthy or allergic donors [44]. We showed 391 
increased susceptibility of glycated BLG to endolysosomal proteolysis. Glycation of BLG 392 
increased content of random structures (as shown by CD spectroscopy), reducing it’s fold 393 
stability and making polypeptide backbone more accessible to endolysosomal proteases. 394 
Intracellular antigen degradation in antigen presenting cells determines the antigen fate [45]. 395 
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Antigens highly susceptible to endolysosomal proteases are known to possess weak capacity 396 
of T-cell priming [46]. This could explain the observed decreased T-cell stimulation by 397 
glycated BLG. 398 
In conclusion, in this study, we found that BLG glycated in MR showed reduced 399 
transepithelial transport, but higher uptake by BMDC. It appeared that both native and 400 
glycated BLG can be endocytosed by BMDCs via SRs, but MR made BLG a better ligand for 401 
SRs possibly through lowering pI value and aggregates formation and thus increased its 402 
uptake. Glycated BLG was more prone to endolysosomal degradation and showed lower 403 
potential to induce cytokine production in coculture of BMDCs with BLG-specific CD4+ T-404 
cells. Glycated BLG also induced lower effector response i.e. reduced basophil activation. 405 
Altogether, our results showed that glycation of BLG influences its interactions with cells 406 
involved in the (allergic) immune response, and also that glycated BLG could be less potent 407 
in the induction of Th2 type responses in a host primarily sensitized to native BLG. 408 
Interestingly, up to now literature data about sensitizing potential of glycated BLG is still 409 
missing. Future studies are needed to elucidate importance of MR on allergenicity and 410 
immunogenicity of BLG in vivo. The present study contributes to the knowledge regarding 411 
the effects of food processing on food allergies and it is of great importance for 412 
considerations of pros and cons of food processing. 413 
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FIGURE LEGENDS 504 
Figure 1. Characterization of BLG glycated in MR. (A) Estimation of the degree of MR 505 
by determining remaining free amino group content by OPA method. Free amino group 506 
content was statistically compared by Student’s t-test. **** denotes significance at p<0.0001 507 
confidence level. (B) Protein profile of native and glycated BLG on 14% SDS-PAGE gel 508 
under non-reducing (NR) and reducing (R) conditions. Protein bands were stained with CBB. 509 
1: native BLG; 2: glycated BLG; 3: molecular weight markers (kDa). (C) CD spectra of 510 
native and glycated BLG in far-UV spectral range. Samples were recorded in 50 mM sodium 511 
phosphate buffer, pH 8.0 at protein concentration 0.85 mg/ml. (D) Percentages of the 512 
secondary structures were estimated by CONTIN algorithm available in CDPro package 513 
based on SP29 reference set. Secondary structure fractions were compared by Student’s t-test. 514 
* represents significance at p<0.05 confidence level. 515 
Figure 2. Bioavailability of native and glycated BLG in vitro. Transcytosis of native and 516 
glycated BLG across Caco-2 monolayer. Transport was measured by determining BLG 517 
concentration in samples withdrawn from basolateral chamber at different time-points up to 3 518 
h. Each point represents the mean ± SD. One representative experiment out of three 519 
independent is shown. *, ** and ***, represent significance at p<0.05, 0.01 and 0.001, 520 
respectively. 521 
Figure 3. BMDCs uptake of FITC labeled native and glycated BLG followed in time. 522 
BMDCs were incubated with 10 µg/ml FITC labeled native and glycated BLG for 120 523 
minutes and the BMDC uptake was analyzed by means of flow cytometry. Data are 524 
expressed as A) percent of FITC positive BMDCs and B) MFI. **, and ****, represent 525 
significance at p<0.01 and 0.0001, respectively. (C) Confocal micrographs of BMDC 526 
incubated with FITC labeled native and glycated BLG for 30 minutes. 527 
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Figure 4. Mechanistic studies of uptake of FITC labeled native and glycated BLG in 528 
presence of different inhibitors. BMDCs were pre-incubated for 30 minutes with (A) 529 
mechanism specific inhibitors, namely: latrunculin B – inhibitor of actin polymerization; 530 
jasplackinolide – inhibitor of phagocytosis; amiloride – macropinocytosis inhibitor; 531 
phenylarsine oxide – inhibitor of receptor-mediated endocytosis, or with (B) receptor specific 532 
inhibitors: dextran sulfate and polyinosine – SRs inhibitors; FPS-ZM1 – RAGE inhibitor. 533 
Subsequently, cells were loaded with 10 µg/ml FITC labeled native and glycated BLG. 534 
BMDCs uptake was analyzed by flow cytometry, and data are represented as percent of MFI 535 
of non-inhibited uptake as mean ± SEM (n = 6) and analyzed by Student’s t-tests. **, ***, 536 
and ****, represent significance at p<0.01, 0.001, and 0.0001, respectively. Mechanistic 537 
studies in the presence of (C) mechanism specific inhibitors or (D) receptor specific 538 
inhibitors were additionally followed by confocal microscopy. 539 
Figure 5. Kinetics of endolysosomal degradation of native and glycated BLG. BMDC 540 
were allowed to internalize native and glycated BLG-coated polystyrene beads and incubated 541 
for different periods at 37 °C to allow endolysosomal degradation. After every time-point 542 
cells were lysed and beads carrying non-degraded BLG were stained by Alexa 488 BLG-543 
specific antibodies. Polystyrene beads were analyzed by flow cytometry. (A) Flow cytometry 544 
dot plot of one representative experiment. (B) Percentage of non-degraded native and 545 
glycated BLG over time is shown as mean ± SEM (n=4). **** denotes significance at 546 
p<0.0001 confidence level. 547 
Figure 6. Stimulation of BLG-specific CD4+ T-cells by native or glycated BLG-primed 548 
BMDCs. CD4+ T-cells isolated from C3H/HeOuJ mice immunized with native BLG were 549 
cocultured with BMDCs primed with native or glycated BLG for 72 hours. Levels of INF-γ, 550 
IL-5, IL-10 and IL-13 in coculture supernatants were measured by ELISA. The data are 551 
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presented as mean ± SD of one representative experiment and analyzed by Student’s t-test. 552 
**, ***, and ns, represent p<0.01, 0.001, and not significant, respectively. 553 
Figure 7. IgE crosslinking-induced luciferase expression assay demonstrating basophil 554 
activation by native and glycated BLG. RS-ATL8 cells sensitized with the pool of BLG-555 
specific chimeric human IgE monoclonal antibodies and subsequently stimulated with 1, 10, 556 
100 or 1000 ng/ml of native and glycated BLG. Luciferase expression level after 1h of 557 
stimulation is shown. Dashed line shows luciferase expression after stimulation with 1 µg/ml 558 
anti-human IgE antibodies. Data are expressed as mean ± SD (n = 8) and analyzed by t-tests. 559 
* p<0.05. 560 
 561 
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METHODS 
Isolation of BLG from cow’s milk 
Cow’s milk was centrifuged at 4000 x g for 30 min at 4 °C to obtain skimmed milk. Casein was 
precipitated by lowering pH to 4.6 and removed by centrifugation at 4000 x g for 30 min. 
Resulting whey was defatted by tetrachloroethylene extraction (2:1 v/v) and dialysed against 20 
mM Tris buffer pH 7.5. DEAE Sephadex A-50 (GE Healthcare, Uppsala, Sweden) was 
equilibrated with 20 mM Tris pH 7.5 and adsorbed whey proteins were eluted by a salt step 
gradient ranging from 40 mM to 280 mM NaCl. Fractions containing purified BLG were 
dialysed against 50 mM phosphate buffer pH 8.0 and concentrated. Purity of the obtained BLG 
preparation was estimated to be >95% by SDS-PAGE. Protein concentration was determined by 
bicinhoninic acid (BCA) assay (Pierce, Amsterdam, The Netherlands). 
Caco-2 cell culture 
The human colon cancer cell line, Caco-2, was obtained from American Type Culture Collection 
(Rockville, MD, USA). Cells were cultured in DMEM (Gibco, Invitrogen, Carlsbad, CA, USA) 
supplemented with 1% nonessential amino acids, 20% heat-inactivated Fetal Calf Serum (FCS) 
and 1% of a mixture of penicillin and streptomycin (10 000 units and 10 mg/ml, respectively) at 
37 °C in a humidified atmosphere of 5% CO2. Cells were subcultured weekly after reaching 
approximately 80% confluence and the culture medium was changed three times per week. 
Coupling of native and glycated BLG to polystyrene beads 
Polystyrene beads (Polysciences, Inc., Warrington, PA, USA) were pre-activated with 8% (v/v) 
glutaraldehyde for 4h at room temperature. Approximately 1.7 x 108 beads were conjugated to 
native and glycated BLG (0.5 mg/ml, 0.5 ml) on a rotating wheel overnight at 4 °C. After 
quenching unreacted groups with 0.5 M glycine for 30 min, beads were used for endolysosomal 
degradation assays. 
RESULTS 
Heated BLG prepared under the same conditions as glycated BLG but in the absence of glucose 
(10 mg/ml BLG, 50 mM sodium phosphate buffer, pH 8.0, 60 °C for 10 days) was compared to 
glycated BLG in terms of protein structure and aggregation. In comparison to native BLG, 
heated and glycated BLG underwent different structural changes. SDS-PAGE analysis under 
non-reducing conditions (Fig. S1A) showed that heated sample was polymerized, with no free 
monomer form. Glycated BLG was present in form of monomer, dimer and polymer. Reducing 
SDS-PAGE (Fig. S1B) revealed heated BLG in monomer, dimer, trimer and polymer form 
suggesting that the most of the covalent bonds were disulfide bridges. Glycated BLG showed 
almost the same electrophoretic pattern under both reducing and non-reducing conditions 
suggesting formation of only non-disulfide covalent bonds. 
 Figure S1. Protein profile of heated and glycated BLG on 12% SDS-PAGE gel under (A) non-reducing and (B) 
reducing conditions. Protein bands were stained with CBB. 
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Figure S2. (A) CD spectra of native and glycated BLG in far-UV spectral range. (B) Percentages of the secondary 
structures were estimated by CONTIN algorithm available in CDPro package based on SP29 reference set. 
Secondary structure fractions were compared by Student’s t-test. * and ** represent significance at p<0.05 and 0.01 
confidence level, respectively. 
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In addition, far-UV CD spectra showed significant difference in secondary structures between 
heated and glycated BLG (Fig. S2A). In comparison to native BLG, both heated and glycated 
BLG showed shift of peak minimum towards lower wavelengths, but peak of heated BLG was 
more profound indicating more significant loss of beta sheets. Indeed, estimation of secondary 
structure content using CONTIN algorithm showed significant difference between heated and 
glycated BLG in the content of α-helix, β-turn and β-strand (Fig. S2B). Glycated BLG was 
characterized with significantly (P>0.01) higher β-strand content, as well as lower α-helix and β-
turn content (P>0.05), compared to heated BLG. 
Taken together, the addition of sugar partially protects BLG from heat-induced denaturation, and 
structural changes induced by Maillard reaction are not the result of additive effect of thermal 
treatment and covalent binding of sugar. Maillard reaction is a complex process that results in 
unique protein modification rather than the simple sum of covalent attachment of sugar moieties 
and thermally induced structural changes. Therefore, it would have been very difficult to use 
heated BLG as a reference and interpret the results in comparison to the heated sample. 
